Trifecta Gold (TRRFF)
OTHER OTC:TRRFF
Holding TRRFF?
Track your performance easily

Trifecta Gold (TRRFF) Income Statement

5 Followers

Trifecta Gold Income Statement

Last quarter (Q2 2024), Trifecta Gold's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, Trifecta Gold's net income was C$-139.80K. See Trifecta Gold’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 396.40KC$ 230.73KC$ 284.81KC$ 437.89KC$ 208.40KC$ 317.71K
Operating Income
C$ -396.40KC$ -230.73KC$ -284.81KC$ -437.89KC$ -208.40KC$ -317.71K
Net Non Operating Interest Income Expense
C$ 24.26KC$ 29.39KC$ 14.53KC$ 3.18KC$ -1.40KC$ -2.47K
Other Income Expense
C$ -1.81KC$ -1.81K--C$ 3.01KC$ 43.08K
Pretax Income
C$ -372.02KC$ -203.15KC$ -688.35KC$ -432.96KC$ -206.78KC$ -363.26K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -372.02KC$ -203.15KC$ -688.35KC$ -432.96KC$ -206.78KC$ -363.26K
Basic EPS
C$ -0.02-C$ -0.01C$ -0.01-C$ -0.01
Diluted EPS
C$ -0.02-C$ -0.01C$ -0.01-C$ -0.01
Basic Average Shares
C$ 200.47MC$ 80.10MC$ 80.10MC$ 69.44MC$ 44.99MC$ 36.49M
Diluted Average Shares
C$ 200.47MC$ 80.10MC$ 80.10MC$ 69.44MC$ 44.99MC$ 36.49M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 396.40KC$ 230.73KC$ 284.81K---
Interest Expense
------
Net Income From Continuing And Discontinued Operation
C$ -372.02KC$ -203.15KC$ -688.35KC$ -432.96KC$ -206.78KC$ -363.26K
Normalized Income
C$ -339.79KC$ -149.32KC$ -90.74KC$ -318.23KC$ -151.98KC$ -230.95K
EBIT
C$ -372.02KC$ -203.15KC$ -688.35KC$ -432.96KC$ -206.78KC$ -363.26K
EBITDA
C$ -372.02KC$ -203.15KC$ -688.35KC$ -432.96KC$ -206.78KC$ -363.26K
Currency in CAD

Trifecta Gold Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis